We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb Co | NYSE:BMY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 43.70 | 0 | 01:00:00 |
From May 2019 to May 2024
By Josh Beckerman
Bristol-Myers Squibb Co. said Giovanni Caforio will succeed Lamberto Andreotti as chief executive in May.
Mr. Andreotti, 64, will become executive chairman in May and will remain chairman after his retirement in August.
Mr. Caforio, 50, joined the company in 2000 and was named chief operating officer last year.
The drug company's current chairman, James M. Cornelius, 71, has chosen not to stand for re-election to the board, the company said.
Write to Josh Beckerman at josh.beckerman@wsj.com
Access Investor Kit for Bristol-Myers Squibb Co.
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US1101221083
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Bristol Myers Squibb Chart |
1 Month Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
